Align Technology (ALGN) The 44th Annual William Blair Growth Stock Conference summary
Event summary combining transcript, slides, and related documents.
The 44th Annual William Blair Growth Stock Conference summary
31 Jan, 2026Company History and Strategic Direction
27 years of innovation in dental aligners, evolving from a startup to a global leader in 3D printing and digital orthodontics, with over 17.6 million Invisalign patients treated globally and a network of 261,000 trained doctors.
Focused on a patient-centric, direct-to-doctor model, emphasizing clinical efficacy, safety, and accessibility for all ages.
Maintains a dedicated sales and clinical education force of 5,000 and 22,000 employees as of March 2024.
Strategic growth drivers include international expansion, patient demand, orthodontic conversion, and GP engagement.
Avoids unrelated acquisitions, focusing exclusively on orthodontic and dental solutions.
Product and Technology Innovation
Launched iTero Lumina scanner, Multi-Direct Capture technology, and Invisalign Smile Architect platform, with iTero scanners surpassing 100,000 units sold and the new Lumina model offering a 3x wider field of capture.
Developed proprietary plastics, SmartTrack, and SmartForce technologies, enabling treatment of 100% of orthodontic cases and optimizing aligner performance.
AI and machine learning have powered treatment planning and product development for over a decade, enabling personalized, efficient care.
3D printing advancements enable direct fabrication of devices, reducing material waste by 90% and allowing for custom material placement.
Invisalign Palatal Expander System offers up to 9mm expansion, available in the US, Canada, Australia, and New Zealand, with phased global rollout pending regulatory approvals.
Financial Performance and Market Trends
Q1 2024 total revenues reached $997.4M, up 5.8% year-over-year, with clear aligner revenues at $817.3M and systems/services at $180.2M.
Clear aligner case volume grew 2.4% year-over-year, with international shipments up 5.3% year-over-year.
Non-case clear aligner revenues, including Vivera retainers and subscription programs, rose 7.5% year-over-year.
Systems and services revenues increased 17.5% year-over-year, with intraoral digital scans for Invisalign case submission at 95.6% in the Americas.
Full-year revenue guidance raised to 7% growth at the midpoint, reflecting stable market conditions and product momentum.
Latest events from Align Technology
- Broad-based growth, strong DSO performance, and stable outlook drive confidence for 2026.ALGN
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - Strong growth in Europe and APAC, with product innovation and efficiency boosting margins.ALGN
Leerink Global Healthcare Conference 202610 Mar 2026 - Record Q4 and FY2025 results, robust Clear Aligner growth, and strong 2026 outlook.ALGN
Q4 20254 Feb 2026 - Digital dentistry expansion, AI-driven innovation, and global growth drive strong financial outlook.ALGN
Investor Day 20253 Feb 2026 - Q2 2024 revenue up 2.6% to $1.03B; margin pressured by FX, mix, and legal settlement.ALGN
Q2 20243 Feb 2026 - Raised guidance and new products drive growth, margin expansion, and digital adoption.ALGN
Jefferies Global Healthcare Conference31 Jan 2026 - Stable market, teen growth, new products, and flexible strategies drive future expansion.ALGN
Baird's 2024 Global Healthcare Conference21 Jan 2026 - Q3 revenue rose 1.8% year-over-year to $977.9M; restructuring and $275M buyback announced.ALGN
Q3 202419 Jan 2026 - Growth investments, digital innovation, and global expansion drive recovery and future margin gains.ALGN
UBS Global Healthcare Conference 202414 Jan 2026